Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-23T12:30:20.286Z Has data issue: false hasContentIssue false
  • English
  • Français

Lithium augmentation in antidepressant-resistant patients

Published online by Cambridge University Press:  02 January 2018

Alastair Flint
Alastair Flint*
Affiliation:
Department of Psychiatry, Toronto General Hospital, Toronto, Canada M5G 2C4
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 160 , Issue 5 , May 1992 , pp. 710
Copyright
Copyright © The Royal College of Psychiatrists, 1992 

References

Georgotas, A., McCue, R., Hapworth, W., et al (1986) Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly. Biological Psychiatry, 21, 1155–1166.CrossRefGoogle ScholarPubMed
Guscott, R. & Grof, P. (1991) The clinical meaning of refractory depression: a review for the clinician. American Journal of Psychiatry, 148, 695–704.Google Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.Google Scholar
Quitkin, F. M., Rabkin, J. G., Ross, D., et al (1984) Duration of antidepressant drug treatment. What is an adequate trial? Archives of General Psychiatry, 41, 238–245.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.